These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 815444)

  • 1. Replication of dengue viruses in cultures of peripheral blood leukocytes from dengue-immune rhesus monkeys.
    Marchette NJ; Halstead SB; Chow JS
    J Infect Dis; 1976 Mar; 133(3):274-82. PubMed ID: 815444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytohemagglutinin enhancement of dengue-2 virus replication in nonimmune rhesus monkey peripheral blood leukocytes.
    Marchette NJ; Halstead SB
    Infect Immun; 1978 Jan; 19(1):40-5. PubMed ID: 203535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection.
    Halstead SB; O'Rourke EJ; Allison AC
    J Exp Med; 1977 Jul; 146(1):218-29. PubMed ID: 195000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dengue virus replication in cultures of peripheral blood leukocytes during the course of dengue haemorrhagic fever.
    Marchette NJ; Sung Chow JS; Halstead SB; Lolekha S; Pongpanich B
    Southeast Asian J Trop Med Public Health; 1975 Sep; 6(3):316-21. PubMed ID: 816007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody.
    Halstead SB; O'Rourke EJ
    J Exp Med; 1977 Jul; 146(1):201-17. PubMed ID: 406347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of leukocytes permissive to dengue 2 virus in the acute phase of dengue hemorrhagic fever.
    Marchette NJ; O'Rourke T; Scott RM; Nimmannitya S; Halstead SB; Bancroft WH
    Am J Trop Med Hyg; 1979 May; 28(3):570-6. PubMed ID: 453450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on dengue 2 virus infection in cyclophosphamide-treated rhesus monkeys.
    Marchette NJ; O'Rourke T; Halstead SB
    Med Microbiol Immunol; 1980 Feb; 168(1):35-47. PubMed ID: 6770237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of immune status on dengue 2 virus replication in cultured leukocytes from infants and children.
    Marchette NJ; Halstead SB; O'Rourke T; Scott RM; Bancroft WH; Vanopruks V
    Infect Immun; 1979 Apr; 24(1):47-50. PubMed ID: 572345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of dengue virus replication in vitro by rimantadine hydrochloride.
    Koff WC; Elm JL; Halstead SB
    Am J Trop Med Hyg; 1981 Jan; 30(1):184-9. PubMed ID: 7212165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody.
    Halstead SB
    J Infect Dis; 1979 Oct; 140(4):527-33. PubMed ID: 117061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dengue virus replication enhancement in peripheral blood leukocytes from immune human beings.
    Halstead SB; Marchette NJ; Sung Chow JS; Lolekha S
    Proc Soc Exp Biol Med; 1976 Jan; 151(1):136-9. PubMed ID: 1250839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of dengue virus replication by amantadine hydrochloride.
    Koff WC; Elm JL; Halstead SB
    Antimicrob Agents Chemother; 1980 Jul; 18(1):125-9. PubMed ID: 7416739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction of mutations into the non-structural genes or 3' untranslated region of an attenuated dengue virus type 4 vaccine candidate further decreases replication in rhesus monkeys while retaining protective immunity.
    Hanley KA; Manlucu LR; Manipon GG; Hanson CT; Whitehead SS; Murphy BR; Blaney JE
    Vaccine; 2004 Sep; 22(25-26):3440-8. PubMed ID: 15308370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
    Guirakhoo F; Weltzin R; Chambers TJ; Zhang ZX; Soike K; Ratterree M; Arroyo J; Georgakopoulos K; Catalan J; Monath TP
    J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathogenesis of dengue infection in the rhesus monkey.
    Marchette NJ; Halstead SB
    Transplant Proc; 1974 Jun; 6(2):197-201. PubMed ID: 4208756
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunological sensitization following inapparent infection with dengue virus type 3 in rhesus monkeys.
    Lubiniecki AS; Tarr GC
    Experientia; 1977 Mar; 33(3):330-1. PubMed ID: 404181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of passage history on dengue-2 virus replication in subpopulations of human leukocytes.
    Brandt WE; McCown JM; Top FH; Bancroft WH; Russell PK
    Infect Immun; 1979 Nov; 26(2):534-41. PubMed ID: 121109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro virulence marker: growth of dengue-2 virus in human leukocyte suspension cultures.
    Halstead SB; Tom MC; Elm JL
    Infect Immun; 1981 Jan; 31(1):102-6. PubMed ID: 7216440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication of dengue-2 virus in cultured human lymphoblastoid cells and subpopulations of human peripheral leukocytes.
    Theofilopoulos AN; Brandt WE; Russell PK; Dixon FT
    J Immunol; 1976 Sep; 117(3):953-61. PubMed ID: 1085314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.